reviewTop 1% cited
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
European Urology · 2021 · Vol. 81(1) · pp. 75–94
Marko Babjuk✉(Vienna General Hospital)Maximilian Burger(University of Regensburg)Otakar Čapoun(Charles University)Daniel L. Cohen(Royal Free London NHS Foundation Trust)Éva Compérat(Sorbonne Université)J.L. Domínguez Escrig(Fundación Instituto Valenciano de Oncología)Paolo Gontero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)Fredrik Liedberg(Skåne University Hospital)A. Masson-Lecomte(Assistance Publique – Hôpitaux de Paris)Hugh Mostafid(Royal Surrey County Hospital)Joan Palou(Universitat Autònoma de Barcelona)Bas W.G. van Rhijn(The Netherlands Cancer Institute)Morgan Rouprêt(Sorbonne Université)Shahrokh F. Shariat(Vienna General Hospital)Thomas Seisen(Pitié-Salpêtrière Hospital)Viktor Soukup(Charles University)Richard Sylvester(European Association of Urology)
Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesColorectal Cancer Screening and DetectionMedicineCarcinoma in situCystoscopyBladder cancerUrologyCarcinomaCancerInternal medicineUrinary system
MeSH terms
Administration, IntravesicalBCG VaccineUrinary Bladder NeoplasmsCarcinoma in SituFemaleHumansMaleNeoplasm InvasivenessUrology
Citations
1,541
FWCI
233.75
field-weighted impact
References
174
Percentile
100%
vs. same field & year
Citations per year
Cited by
Factors predicting presence/absence of Detrusor muscle in TURBT specimen
International Journal of Surgery Science · 2025 · 0 citations
References
Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression
Urology · 2004 · 458 citations
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
European Urology · 2006 · 2,943 citations
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
The Journal of Urology · 2016 · 1,534 citations
Going from evidence to recommendations
BMJ · 2008 · 1,776 citations
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
The Journal of Urology · 2002 · 1,296 citations
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
European Urology · 2009 · 650 citations
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
The Journal of Urology · 2000 · 1,298 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.